A CLINICAL STUDY OF PANDUROGA WSR TO IRON DEFICIENCY ANEMIA

Similar documents
INTRODUCTION Rakta has been considered as a key. Drugs like Haritaki, Amalaki, Pippali, Shilajatu, Makshika, Loha, Mandura, Abhraka

CLINICAL EVALUATION MIA

Rashmi TM et al / Int. J. Res. Ayurveda Pharm. 5(6), Nov - Dec Research Article.

Nabanita Chakrabarty et al. Int. Res. J. Pharm. 2017, 8 (7) INTERNATIONAL RESEARCH JOURNAL OF PHARMACY

Hari Krishna C et al. Journal of Biological & Scientific Opinion Volume 2 (2). 2014

IJMSS Vol.03 Issue-09 (September, 2015) ISSN: International Journal in Management and Social Science (Impact Factor- 4.

CLINICAL EFFICACY TWAKNAGAPUSHPADI CHURNA (PANA) IN MADATYAYA W.S.R. TO CHRONIC ALCOHOLISM

EFFICACY OF DHATRI AVALEHA IN PANDU (NUTRITIONAL ANAEMIA) AN OPEN END RANDOMIZED CLINICAL TRIAL

A B S T R A C T INTRODUCTION OBJECTIVE OF THE STUDY. ISSN: ORIGINAL ARTICLE Mar-Apr Gujarat, India.

AYUSHDHARA. An International Journal of Research in AYUSH and Allied Systems. Research Article

THE CLINICAL EVALUATION OF YASHTIMADHU CHURNA WITH MADHU FOR CORRECTION OF PANDUROGA W.S.R. TO IRON DEFICIENCY ANAEMIA AND MEGALOBLASTIC ANAEMIA.

International Journal of Applied Ayurved Research ISSN: STANDARD OPERATING PROTOCOL OF GANDOOSHA & KAVALA

A Study on Ayurveda Poly Herbal Compound of Yogaratnakar (17 - A.D.) w.s.r. Rakta-Pradara (Abnormal Uterine Bleeding)

Pharma Science Monitor 6(3), Jul-Sep 2015 PHARMA SCIENCE MONITOR

World Journal of Pharmaceutical and Life Sciences WJPLS

A B S T R A C T INTRODUCTION OBJECTIVE OF THE STUDY. ISSN: ORIGINAL ARTICLE Mar-Apr Limbda, Vadodara.

Greentree Group Publishers

Stress Induced IBS and its Ayurvedic Management- A Case Study Urja Singh 1 * and Akhilesh Shrivastava 2

Pushpawati Chaudhari. et al. / International Journal of Biopharmaceutics. 2013; 4(2): International Journal of Biopharmaceutics

Dr. Kruti Y Vyas [MD (AYU)]

A NIDANATMAKA (EPIDEMIOLOGICAL) STUDY ON MUTRASHMARI

Therapeutic efficacy of Shirishavaleha prepared by Water and Kanji as liquid media and its effect on Tamaka Shwasa (Bronchial Asthma)

EFFICACY OF MATRA BASTI AND MEDHYA RASAYANA IN THE MANAGEMENT OF KLAIBYA ROGA

CLINICAL EFFICACY OF AMAVATARI RASA IN THE MANAGEMENT OF RHEUMATOID ARTHERITIS

EFFECT OF VYOSHADI GHRITA ON PANDU W.S.R. TO IRON DEFICIENCY ANEMIA

DEPARTMENT OF KAYACHIKITSA J. S. AYURVEDA COLLEGE, NADIAD

ROLE OF RASA SINDHURA IN RESPIRATORY DISORDERS W.S.R TOTAMAKA SWASA

THE EFFECT OF DIET AND LIFESTYLE ON TREATMENT WITH GUDUCHYADI

PRESENTING A WORK DONE BY Dr. DEVANGI PATEL IN THE YEAR 2004.

International Journal of Applied Ayurved Research ISSN: EFFICACY OF EKAVINSHATIKA GUGGULU IN THE MANAGEMENT OF VICHARCHIKA

Understanding Essential Hypertension through Ayurveda A Review

EVALUATION OF VIRECHANA KARMA AND SIRAVEDHA KARMA IN EK- KUSHTHA (PSORIASIS) A PILOT STUDY

STUDY ON MENTAL HEALTH DISTURBANCE IN MENOPAUSAL SYNDROME AND ITS MANAGEMENT WITH MEDHYA RASAYANA AND SHIRODHARA

A CLINICAL STUDY ON ETIOPATHOGENESIS OF STHAULYA AND ITS MANAGEMENT WITH MEDOHAR COMPOUND

World Journal of Pharmaceutical and Life Sciences WJPLS

Clinical Evaluation Of Asana Kashay In Sthaulya W.S.R. To Obesity

A CLINICAL STUDY ON THE CONCEPT OF KARNANADA &KARNAKSHVED WITH SPECIAL REFFERENCEE TO TINNITUS

World Journal of Pharmaceutical and Life Sciences WJPLS

Research Article International Ayurvedic Medical Journal ISSN:

STUDY OF HYPOTHYROIDISM AS AN ANUKTA VYADHI

Role of Dhatryadi Rasakriya Anjana in Refractive errors

A CLINICAL STUDY OF PANDUGHNI VATI ON PANDU W.S.R. To IRON DEFICIENCY ANEMIA IN CHILDREN

Ayurvedic Management of Benign Prostatic Hyperplasia (bph) Patel Kalapi 1 *, Patel Manish 2, Shah N K 3, Gupta S N 4 and Jain Jinesh 5

MANAGEMENT OF MIGRAINE (ARDHAVABHEDAKA) WITH KUMKUMADI GHRITA NASYA: A CASE REPORT

International Journal of Ayurveda and Pharma Research

MANAGEMENT OF MADHUMEHA WITH SPECIAL REFERENCEE TO DIABE- TES MELLITUS

Research Article International Ayurvedic Medical Journal ISSN: THE IMPORTANCE OF SROTOMOOLA CHIKITSA- A CLINICAL STUDY W.S.

Research Article

THE ROLE OF VIRECHANA KARMA WITH BAKUCHI CHURNA AND AV- ALGUJBEEJADI LEPA IN THE MANAGEMENT OF SHWITRA (VITILIGO)

PHARMACOGNOSTICAL AND PHARMACEUTICAL STUDY OF NAVAYASA CHURNA IN THE MANAGEMENT OF PANDU W.S.R. TO IRON DEFICIENCY ANAEMIA (IDA)

Clinical evaluation of Saptavimshatika Guggulu and Haridra Churna in the management of Type-2 Diabetes Mellitus

STUDY OF VITAMIN B12 DEFICIENCY WITH SPECIAL REFERENCE PANDU VYADHI

ROLE OF NAVAYASA LAUHA IN THE MANAGEMENT OF IRON DEFICIENCY ANAEMIA

Ayurved Darpan - Journal of Indian Medicine

IJAYUSH International Journal of AYUSH

International Journal of Applied Ayurved Research ISSN: A REVIEW ARTICLE-AYURVEDIC MANAGEMENT OF VICHARCHIKA (ECZEMA) THROUGH KANKARISTHA

AN AYURVEDIC MANAGEMENT OF RAJONIVRITTI JANYA LAKSHANA (MENOPAUSAL SYNDROME)

Greentree Group Publishers

An Analysis of Virechana Karma with Hridya Virechana Leha in the Management of Psoriasis Cyrus Neupane 1 * and Niranjan Rao 2

A CLINICAL EVALUATION OF RAKTA MOKSHANA IN THE MANAGEMENT OF SANDHIGATA VATA W.S.R. TO LUMBAR SPONDYLOSIS. DR.FORAM JOSHI Final Year MS (AYU, SCHOLAR)

An Observational Clinical Study of Navayasalauha Tablets w.s.r. to Iron Deficiency Anemia Joshi Nirali B. 1 *and Shankar M. B. 2

Study the etiopathogenesis of hyperlipidaemia and action of lekhaniya mahakashaya vati.

ISSN: CASE STUDY OF GREEVA

A clinical study on the role of herbal compound belfaladi churna in the management of atisaar

International Journal of Applied Ayurved Research ISSN: ROLE OF VIRECHANA KARMA IN DADRU (TINEA CORPORIS) - A CLINICAL STUDY 1

Role of Shwasahara Dashemani in the Management of Tamakashwasa (bronchial asthma) - A single case study

A B S T R A C T INTRODUCTION. ISSN: ORIGINAL ARTICLE July-Aug Institute of Ayurvedic Medical Sciences, Manipal, Karnataka, INDIA.

Int J Ayu Pharm Chem. e-issn Sapna Chaudhary 1 *and Vinod Kumar Joshi 2 RESEARCH ARTICLE

A Clinical Study of Ayurvedic Treatment on Polycystic Ovarian Syndrome (PCOD)

International Journal of Applied Ayurved Research ISSN: AUSHADHA SIDDHA AHARA KALPANA IN AYURVEDA: A CRITICAL REVIEW 1 Vijay Patha

International Journal of Advancements in Research & Technology, Volume 2, Issue 11, November ISSN

Role of Matra Basti with AhacharadiTail in the Management of Gridharasi (Sciatica) Rita Khagram 1 *and Megha Pandya 2

The role of Phalaghrita Uttarbasti in the management of Infertility w.s.r. Cervical Factor

VADI ASCHYOTANA (EYEE DROPS) IN THE TREATMENT OF COMPUTER VISION SYNDROME

World Journal of Pharmaceutical and Life Sciences WJPLS

PANDU) AS AN ADJUVANT THERAPY - A CASE STUDY

Observational study of Amla Sheet Food Craving in Anaemic Patients

Impact factor: 3.958/ICV:

AYUSHDHARA. An International Journal of Research in AYUSH and Allied Systems. Research Article

World Journal of Pharmaceutical Research SJIF Impact Factor 6.805

ANVESHANA CLINICAL STUDY TO EVALUATE THE EFFICACY OF RASAYANA AND NASYA IN THE MANAGEMENT OF KHALITYA (HAIR FALLING)

Impact factor: 3.958/ICV:

ISSN: ROLE OF SHAMAN PURVA SAMSHODHANA (PURIFICATION) IN THE MANAGEMENT OF KSHINA-SHUKRA (OLIGOZOOSPERMIA)- REVIEW STUDY

Int J Ayu Pharm Chem. e-issn

!!"# $%&'()*+,-./ %0405.6)*01)7*%()7,.8(91)7,

International Journal of Applied Ayurved Research ISSN: EFFECT OF YASHTIMADHU IN THE MANAGEMENT OF PITTA PRAKOPA

A clinical study of Shunthyadi churna in the Management of Tamaka shwasa W.S.R. to Bronchial Asthma

Leucorrhoea in ayurvedic review

Int J Ayu Pharm Chem. e-issn

3 Dave Hetal H. 3 Asst. Professor, SRPT Dept., N.I.A. Jaipur.

International Journal of Ayurveda and Pharma Research

International Journal of Applied Ayurved Research ISSN: ACTION OF AVIPATTI CHURNAM: AN AYURVEDIC PERSPECTIVE 1 Rajalekshmy.P.

ANVESHANA EFFECT OF ARAGVADHA PATRA KALKA AND ARNALA LEPA WITH AND WITHOUT CHAKRAMARDA SEED POWDER IN DADRU

Parul Kansara et al / Int. J. Res. Ayurveda Pharm. 7(Suppl 3), Jul - Aug Research Article.

Impact factor: 3.958/ICV: 4.10 ISSN:

Sumbe Deepak Tolaji et al / Int. J. Res. Ayurveda Pharm. 5(6), Nov - Dec Research Article.

CLINICAL EVALUATION OF ASHVATHA TWAK KWATHA WITH MADHU IN THE MANAGEMENT OF VATARAKTA W.S.R. TO GOUT

Pharmacological Study of Padm-Keshar (Nelumbo nucifera) on Dysfunctional Uterine Bleeding (DUB)

ASSESSMENT OF EFFICACY OF VAMANA KARMA IN THE MANAGEMENT OF VICHARCHIKA

A COMPARATIVE STUDY OF HARITAKI PRAYOGA AND TRIVRUTADI CHURNA IN THE MANAGEMENT OF AMAVATA (RHEUMATOID ARTHRITIS)

Transcription:

Research Article International Ayurvedic Medical Journal ISSN:2320 5091 A CLINICAL STUDY OF PANDUROGA WSR TO IRON DEFICIENCY ANEMIA AND ITS MANAGEMENT WITH DHATRIYARIHTA AND PANDUGHNA VATI Urvi R Dave 1, Anup Thakar 2 1 Asso.Prof. in Departmentt of Roga Nidan Vikriti Vigyan,Parul Institute of Ayurved, Baroda Gujarat, India 2 Asso.Prof & HOD in Department of Panchkarma, IPGT & RA Jamnagar, Gujarat Ayurved University, Gujarat, India ABSTRACT Acharya Charaka has described Panduroga under Rasa Kshayajanya Vyadhi, which may cause malnourishment and deficiency of next Dhatu Rakta (Blood). Classically it can be comdisease charac- pared with the Panduroga by their similar signs and symptoms. Panduroga is a terized by pallor of body which resembles with Anemia of modern science, disease to reduc- tion of Hemoglobin. Iron Deficiency Anemia (IDA) is the most common type of Anemia over- 35 patients all, and is caused when the dietary intake or absorption of Iron is insufficient. Here were selected in the study and randomly divided into two groups. Group A received Dhariyaris- and in- ta, Group B Pandughna Vati received. At the end of 45 days symptomatic improvement crease in Hb% in Group A and Group B were noticed. No significant therapy is there for chronic Anemia in Modern science whichh is often due to metabolic defect, so an attemptt has been made to evaluate the efficacy of both drugs on Iron Deficiency Anemia. Keywords: Panduroga, Iron Deficiency Anemia, Dhatriyarishta, PandughnaVati. INTRODUCTION Pandu, is a disease characterized by pallor of body which resembless with Aneto reduction mia of modern science, disease of Hemoglobin and Pallor of Skin appears. The person with this disease suffers from decreased blood amount, strength and com- of natu- plexion. He becomes Nihsara (loss ral integrity, tone and strength) (1). Rasa and Rakta has been considered as a key factor for the Prirana and Jeevana, Dharana and Poshana karma of the body. Many a times it is seen that Rakta gets vitiated by Doshas, mainly by Pitta dosha as Rakta is Pittavarappear. In giya and disease like Pandu Ayurveda, Pandu is considered as a specific disease with its own pathogenesis and treat- ment And describing under Rasa pradoshaj Vikara (2) due to Agni mandya (Reduced Me- diseases ( nida- tabolism) and other chronicc narthkar roga).rasa dhatvagni mandya leads to Raktakshya (Malnourishment of Rakta, which cause Pandu roga and symp- Hrid dravtva, toms like Panduta, Rukshta, Shwasa Shotha etc were developed (3). The word Anemia in Greek means a lack of blood. Actually it is a deficiency of hemog- grades of this lobin and there are various deficiency. Anemia can result from a large number of causes, including nutritional defi- of blood due to ciencies, acute or slow losss trauma or diseases. Iron deficiency, is the most prevalent nutritional deficiency in the world (4). In modern medicine, there is good treatment for Anemia with considerable re-

sult but that is only for acute deficiencies No significant therapy is there for chronic Anemias which occur due to metabolic defects reported that these drugs has useful role in preventing Pandu roga (IDA) due to its Rejuvenating and Metabolic effect. Aims and Objective: The aim of study was to clinically assess Pandu roga and to evaluate the efficacy of Dhatriyarishta and Pandughna Vati in its management. Materials and Methods: A total of 35 patients randomly selected from outpatients and inpatients department of Roganidan and Kayachikitsa, IPGT&RA, Jamnagar in the year 2006. 6 patients are discontinued during the treatment and 29 patients are treated completely. Criteria for Selection of the Patients Inclusion Criteria: 1. Primarily the Patients were selected on the basis of the presence of classical symptomatology along with some Modern parameters of Panduroga. 2. Patients having Hb% For Female: Below 12 % For Male: Below 13 % Specific Investigation like Serum Iron level and TIBC were also carried out. Serum iron In Male Below 65 177 μg/dl (11.6 31.7 μmol/l); In Female 50 170 μg/dl (9.0 30.4 μmol/l) Total Iron Bounding Capacity: Below 250 370 μg/dl (45-66 μmol/l) were selected. Patients between the age group of 15-50 years were selected for the study. Exclusion Criteria Patients suffering from AIDS, Cancer, Tuberculosis, Diabetes Mellitus and other disease Disorders. Pregnancy Age below 15 years and more than 50 years. Investigations Hb % TC DC ESR 1918 Blood Indices: MCV, MCH, MCHC. Serum Iron Level Total Iron Binding Capacity Routine and Microscopic Urine and Biochemical examinations have excluded. Preparation of Drugs: Both the drugs were prepared in the Pharmacy of IPGT & RA,Gujarat Ayuveda University, Jamnagar. Group A: Dhatriyarishta Ingredients: 1. Amalaki Svarasa 2. Sharakara (sugar) 3. Madhu (honey) Prakshepa Dravya 1. Pippali churna Method of Preparation of Drug: First Dhupana karma was done in porcelain jar, than Amalaki Svarasa was added in it, than Sharkara and Madhu, and in last Pippali churna was added as Prakshepa dravyas. Sandhana was done properly and after 45 days Arishta was carried out from the jar, filtered well and packed in brown bottle. Group B: Pandughna vati (Anubhut yoga) Ingredients Churna Dravyas: 1. Amlaki - Fruit part 2. Bibhitaki - Fruit part 3. Shunthi - Rhizome part 4. Maricha - fruits part 5. Pippali - fruits part 6. Punarnava -Root part 7. Vidanga Seed part 8. Katuki -Rhizome part Bhavana Drvyas: 1. Gomutra 1 Bhavana 2. Kumari Swarasa 1 Bhavana 3. Punarnavamool 2 Bhavana 4. Amlaki 2 Bhavana Method of Preparation of Drug: All the above drugs were taken in equal quantities and powdered was made of first eight drugs then Bhavana of above four drugs had given with different quantity, andvati of (150 mg) has prepared. Drug, Dose and Duration

Group A: Dhatriyarishta- Dose: 20ml twice a day, Time of administration: Before meal Duration: 45 days, Anupana: Water Group B: Pandughna Vati- Dose: 150mg thrice daily, Time of administration: After meal, Duration 45 days, Anupana : water Changes in patient s status were noted and following points were taken into consideration or assessment of results. To assess the effect of therapy objectively, all the signs and symptoms were given scoring pattern depending upon their severity as below: 1. Panduta (Paleness) In - Tvaka, Nakha, Netravartma, Jihva, Hastapadatala In any 2 of these In any 3 of these - 2 In any 4 of these - 3 In all - 4 2. Daurbalyta (Weakness) After heavy work, relieved soon and tolerate After Moderate work relieved later and tolerate - 2 After little work relieved later - 3 tolerate - 4 3. Hridspandanam (Palpitation) After heavy work,relieved soon and tolerate After Modrate work relieved later and tolrate - 2 After little work relieved later 3 tolrate - 4 Hridaspandanam even in resting condition - 5 4. Bharma (Vertigo) After heavy work, relieved soon and tolerate 1919 After Moderate work relieved later and tolerate - 2 After little work relieved later - 3 tolerate - 4 Bhrama even in resting condition - 5 5. Shunakshikuta Shotha (Oedema around Eyes) Mild Moderate - 2 Severe - 3 6. Rukshata (Dryness) In - Twaka, Nakha, Netravartma, Jihva, Hastapadatala In any 2 of these In any 3 of these - 2 In any 4 of these - 3 In all - 4 7. Shvasa (Dysponea) After heavy work, relieved soon and tolerate After Moderate work relieved later and tolerate - 2 After little work relieved later - 3 tolerate - 4 Shvasa even in resting condition - 5 8. Aruchi (Loss of Appetite) Normal instinct of taking food - 0 Person even dislikes the touch or smell of food Though the person is hungry he had dislike for food Due to fear, anger etc - 2 Person doesn t like to take food due to Sharira/Manas doshas - 3 9. Pindikodveshtanam (Leg Cramps) After heavy work

After moderate work - 2 Only at night but beyond tolerate - 3 Whole day, severe, require medicine - 4 10. Jvara (Fever) No - 0 Occasional Daily once - 2 Constant 3 Follow up: The follow up study of patients were conducted for one month after completion of the treatment. Criteria for Assessment: The improvement in the patient was assessed mainly on the basis of points that given below: Increasing percentage of the Hemoglobin. Improvement in the sign and symptoms of the disease. Improvement in the General Health and other Biological parameters. The outdoor patients were examined weekly. Changes in patient s status were noted. 1920 dered as statistically significant and highly significant respectively. Level of significance was noted and interpreted accordingly Criteria for Assessing the Total Effect: Considering the overall improvement shown by the patient in sign and symptoms, the total effect of the therapy has been assessed as below. It is assessed on the basis of percentage of relief obtained. Criteria for Assessment of Results: Cured: When the sign and symptoms are improved about 75% and above. Markedly improved: When the sign and symptoms are improved about 51% to 75% Improved: When the sign and symptoms are improved about 25% to 50% No improvement: When the sign and symptoms are below 25% Observation and Results: The Effect of Dhatriyarishta on Chief Complaints is shown in Table 1.The Improvement in Haematological Investigations is shown in Table 2 and Improvement in Serum Iron level and in Total Iron Binding Capacity (TIBC) is shown in Table no 3. Table 1: Effect of Dhatriyaishta on Signs and Symptoms of IDA. A.T. % Relief S.D. S.E. t p Statistically Analyzed: The obtained data were analyzed statistically. The values were expressed as Mean ± SEM. The data were analyzed by paired t test. The level of P<0.05 and (P<0.01, P<0.001) was cons i- Sign and Symptoms N(Total Mean 13 pa- B.T. tients Panduta 13 2.15 1 56.73 0.55 0.15 7.5 <0.001 Daurbalyta 13 2.07 0.92 55.55 0.69 0.20 6.04 <0.001 Hridaspandanama 06 1.83 0.83 54.65 0.89 0.36 2.73 <0.05 Bhrama 08 1.75 0.5 71.42 0.46 0.16 7.63 <0.001 Shunakshikut shotha 05 1.4 0.6 57.14 0.44 0.20 4 <0.01 Rukshata 10 2.4 1.6 33.33 0.63 0.20 4 <0.01 Shvasa 06 1.66 0.83 50 0.75 0.30 2.71 <0.05 Aruchi 09 1.66 0.44 33.33 0.72 0.24 2.29 <0.01 Pindikodweshnama 12 2.16 1 53.84 0.57 0.16 7 <0.001 Jvara 05 2.4 1.2 14.86 0.44 0.2 6 <0.001 Table 2: Effect of Dhariyarishta on Haematological Investigations of IDA Investigations N Mean % Relief S.D. S.E. t P Hb% 13 10.77 11.30 4.8 1.17 0.32 1.7 <0.01

TRBC 13 4.22 4.34 2.77 0.22 0.06 2.21 <0.05 MCV 13 80.55 81.4 1.04 3.60 1 0.76 <0.01 MCH 13 25.33 26.2 3.36 1.87 0.57 1.64 <0.1 MCHC 13 31.73 31.8 0.19 1.44 0.4 0.15 <0.1 ESR 13 22.30 20.46 8.17 10.14 2.81 0.65 <0.1 Table 3: Effect of Dhatriyashta on Serum Iron level and TIBC on IDA Investigations N Mean % Relief S.D. S.E. t P Serum Iron /dl 5 34 35 2.94 2.00 0.89 1.11 <0.1 TIBC 5 378 395.8 4.6 9.3 4.15 4.18 <0.05 The Effect of Pandughna vati on Chief Complaints is shown in Table 4.The Improvement rum Iron level and Total Iron Binding Capacity (TIBC) is shown in Table no 6. in Haematological Investigations Table 4: Effect of Pandughna vati on is shown in Table 5 and Improvement in Se- Signs and Symptoms of IDA Sign and Symptoms N(Total 16 patient) Mean B.T. A.T. % Relief S.D. S.E. t p Panduta 11 2.27 0.81 64 0.52 0.13 9.6 <0.001 Daurbalyta 11 2.29 1 65.5 0.45 0.13 14.07 <0.001 Hridaspandanama 09 1.90 1 43.30 0.78 0.26 4.26 <0.01 Bhrama 08 1.87 0.36 80.70 0.5 0.17 7.74 <0.001 Shunakshikut shotha 08 1.87 1 46.50 0.9 0.32 3.56 <0.001 Rukshata 09 3.44 2.44 29.10 0.5 0.16 6.25 <0.01 Shvasa 09 2.1 0.44 79.05 0.52 0.18 8 <0.01 Aruchi 08 6.7 1 63.0 0.7 0.24 7.2 <0.001 Pindikodweshnama 11 2.63 0.81 69.20 0.53 0.16 11.3 <0.001 Jvara 07 1.71 0.57 66.7 0.37 0.14 8.4 <0.001 Table 5: Effect of Pandughna vati on Haematological Investigations of IDA Investigations N Mean % Relief S.D. S.E. t P Hb% 16 10.63 10.91 2.70 4.31 1.07 2.4 <0.05 TRBC 16 4.34 4.41 1.60 4.40 0.12 0.15 <0.1 MCV 16 76.85 86.03 10.7 6.33 1.58 2.93 <0.01 MCH 16 24.9 25.8 3.5 3.18 0.85 1.18 <0.1 MCHC 16 30.7 33.8 9.0 2.11 0.52 2.38 <0.05 ESR 16 28.5 18.75 34.2 18.7 4.67 2.2 <0.05 Table 6: Effect of Pandughna vati on Serum Iron level and TIBC on IDA Investigations N Mean % Relief S.D. S.E. t P Serum Iron 5 35.33 31.33 13.20 5.50 2.46 1.59 <0.05 TIBC 5 352 390 10.80 27.70 12.40 3.06 <0.05 Pandu roga is Pitta pradhana vyadhi, Pitta DISCUSSION AND CONCLUSION is responsible for the normal colour of the 1921

body but when it get vitiated,loss Panduta (Pallor) occurs. Though Pitta is pradhana dosha in Pand roga, Vata dosha also plays crucial role in manifestation of Pandu roga, mainly Vyana vayu has a relation with Samprapti of Pandu roga. Pandu roga can be effectively compared with Anemia on the grounds of its similar signs and symptoms the modern medicine provides good treatment for Anemia with considerable result but that is only for acute deficiency Anemia, no significant therapy is there for chronic Anemia which occurs due to metabolic defects. So Ayurveda can provide better management of this. It is obvious that Anemia is most common among females due to menstruation, poor general health, improper and inadequate diet which leads to malnutrition leading to Iron Deficiency Anemia. Cause of Iron deficiency is improper Iron absorption in the GIT. Ferrous iron can absorb better than Inorganic ferrous and ferric salts. Hemoglobin iron is absorbed intact as Haem, even at neutral ph, and is not affected by dietary maintains the phosphate and phytate. Here in these trial compounds, Pandughna vati which contains Deepana, Pachana dravya? Which increase Gastric acidity through their Ushna and Tikshna guna, and Ushna virya nature helps to destroy the srotorodha. So, metabolism improves, ultimately digestion was improves leads to proper Dhatu poshana. Secound trial compound is Dhatriyarista contains mainly Amalaki, which is best Rasayana, Tridosha hara, Vatanulomak and pitta shamaka. (6), and it is a well known fact that due to its Ashukari and Vyvayi properties of Dhatriyarishta). it get easily absorbed in the body channels (Srotasa) and thus exhibit the properties of applied drugs at a much faster level Amalaki is main in both trial compound, but in different forms and it contains high amount of Vitamin C, which reduces ferric iron to ferrous iron which remains soluble even at neutral ph and is better absorbed. (7) Even when the diet is poor in iron, Vitamin C supplement with each meal enhance iron absorption. Vitamin C taken in divided doses with each meal will increase iron absorption to a greater extent. Hence Dhatriyarishta and Pandughna vati both compound showed highly significant respond in Panduroga due to metabolic effect. REFERENCES: 1. Charaka Samhita (Vol II) Prof P.V. Sharma, Chikitsa Sthana Panduroga Chikitsitam 7 th edi., Chuakhambha Orientalia,273(2005). 2. Charak Samhita (Vol I) Prof P V Sha r- ma, Vividhasheetpitiyadhyay, Sutra Sthana,9 th edition, Chaukhambha orientalia, Varanasi 226(2005) 3. Ashtang Hridaya (Vol II) Prof K.R.Srikantha Murthy, Pandurogashophavisarpanidanam-Nidana sthana, 5 th edition. Chuakhmbha Krishnadas Academy Varanasi 122(2003) A.D. 4. Savill s System of Clinical Medicine 14 edition, LONDON Edward Arnold Publishers 813)1964. 5. Charaka Samhita (Vol II) Prof P V Sharma, Chikitsa Sthana Panduroga Chikitsitam 7 th edi. Chaukhambha Orientalia, 283(2005). 6. Dravyaguna Vijnan (Vol II) Prof.P V Sharma, Chaukhambha Bharti academi758(2006) 7. Davidson: Blood disorders, Principles & Practice of medicine 20 th edition, Charchil living stone ELSEVIER UK 1025(2006) CORRESPONDING AUTHOR Dr. Urvi R Dave Asso.Professor, Department of Roga Nidan Vikriti Vigyan, Parul Institute of Ayurved, Baroda Gujarat, India Email: daveurvi29@rediffmail.com Source of support: Nil Conflict of interest: None Declared 1922